CIMB Research keeps Adventa (7191.KU) with unchanged MYR5.44 target, pegged to 13.2X PE or a 20% discount to peer Top Glove's (7113.KU) target PE of 16.5X. "We like Adventa for its niche in surgical glove and aggressive long term plans to grow its other business segments and become a significant healthcare products supplier in the region," says CIMB; adds company expects sales to increase progressively this year as new capacity from the new high output factory in Kluang and new lines from Kota Bharu plant will allow it to handle more orders. Also expects Uruguay plant to contribute to earnings from 3Q FY10 as utilisation rate has rocketed from 20% to 60%. Stock last +1.7% at MYR3.66. (elffie.chew@dowjones.com)
Maintain Buy, with our target price maintained at RM5.37 based on a PER of 15x FY11 EPS - OSK.
Note: Final Dividend of 4 sen per share tax exempt for the financial year ended 31 October 2009 Xdate 23 March 2010. Seventh Annual General Meeting of ADVENTA is scheduled to be held on Thursday, 25 March 2010
Grumpy Old Man Syndrome
-
Sometimes we stereotypify something because we can see them in substantive
numbers but we may not understand why they occur. Grumpy old men ... we all
hav...
1 year ago
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.